We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Paper-Based Diagnostic Device Detects Infectious Diseases In 10 Minutes

By LabMedica International staff writers
Posted on 03 Jun 2025

Infectious disease diagnosis often requires expensive and complex lab equipment, skilled personnel, and significant time, all of which can be barriers to effective outbreak response in low-resource settings. More...

To address these challenges, scientists have developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes, without the need for sophisticated lab equipment or trained personnel.

The Radially Compartmentalized Paper Chip (RCP-Chip), developed by a team of scientists at NYU Abu Dhabi (Abu Dhabi, UAE), offers a fast, affordable, and portable solution for on-site screening. The RCP-Chip was conceived during the early COVID-19 lockdowns and was developed to detect even minute traces of viral genetic material. It operates without the need for electricity or specialized equipment, requiring only a source of mild heat (around 65°C, similar to warm water).

The chip is made from a single sheet of paper, incorporating miniature components such as sample ports, vents, fluidic resistors, and reaction chambers pre-loaded with primers, enzymes, and gold nanoparticles to facilitate the detection process. In their research published in Advanced Sensor Research, the team has detailed the development and validation of the RCP-Chip. The device functions as a rapid, multiplexed diagnostic platform that allows for the detection of multiple infectious diseases, making it particularly useful for low-resource settings.

The RCP-Chip’s ability to detect SARS-CoV-2 genetic targets in under 10 minutes has been validated in tests, and the device’s effectiveness was demonstrated through its ability to perform multiplexed testing, detecting multiple gene targets in a single run, which increases efficiency while reducing sample volume and cost. The RCP-Chip can be reconfigured to detect a variety of pathogens, including bacteria, viruses, and others, across various sample types such as saliva, blood, and environmental sources.

The device's compact, user-friendly design makes it a powerful tool for field deployment, especially in regions lacking access to traditional diagnostic laboratories. Looking forward, the research team aims to enhance the chip’s plasmonic detection capabilities and expand its use for point-of-care applications. They also plan to explore smartphone connectivity for real-time data sharing and outbreak tracking, further increasing the device’s utility in public health surveillance.

“This is a fast, affordable, lab-free test that detects multiple gene targets in under 10 minutes,” said Pavithra Sukumar, NYUAD Research Assistant and co-first author of the study. “What makes it truly impactful is its real-world potential. This portable test could significantly improve outbreak response by enabling faster isolation, treatment, and control.”

Related Links:
NYU Abu Dhabi


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.